Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial - Dai, Qi; Zhu, Xiangzhu; Manson, JoAnn E; Song, Yiqing; Li, Xingnan; Franke, Adrian A; Costello, Rebecca B; Rosanoff, Andrea; Nian, Hui; Fan, Lei; Murff, Harvey; Ness, Reid M; et al. (The American journal of clinical nutrition, 2018)
Keywords: 24,25-Dihydroxyvitamin D 3 - blood; 25-Hydroxyvitamin D; 25-Hydroxyvitamin D 2 - blood; Adults; Aged; algorithms; Calcifediol - blood; Calcitriol; Calcitriol - blood; Calcium; calcium-to-magnesium ratio; Cancer; Clinical trials; Colorectal cancer; Colorectal carcinoma; colorectal neoplasms; Diet; Dietary intake; Dietary Supplements; enzymes; Ergocalciferols - blood; Female; food intake; Health care facilities; Humans; In vivo methods and tests; in vivo studies; interaction; Kidney - physiopathology; Liquid chromatography; Magnesium; Magnesium - administration & dosage; Magnesium Deficiency - physiopathology; Male; Mass spectrometry; Mass spectroscopy; medical facilities; Metabolism; Middle Aged; mortality; Mortality risk; National Health and Nutrition Examination Survey; nutrition risk assessment; Nutritional Status; Observational studies; Optimization; Original Research Communications; Placebos; randomized clinical trial; randomized clinical trials; United States; Vitamin D; Vitamin D - analogs & derivatives; Vitamin D - blood; Vitamin D Deficiency - physiopathology; vitamin D metabolism; vitamin status; United States; vitamin D metabolism; eGFR; PTAD; 1,25(OH)2D3; magnesium; randomized clinical trial; 1,25(OH)2D2; 1,25(OH)2D; calcium-to-magnesium ratio; CVD; NCI; interaction; NIST; PPCCT; 24,25(OH)2D3; 25(OH)D; 25(OH)D2; TRPM7; CYP; 25(OH)D3; LCMS; subfamily M